1-Hydroxyethylidene-1, 1-Diphosphonic Acid (HEDP) From China, 72510 [2022-25686]
Download as PDF
<![CDATA[
72510
Federal Register / Vol. 87, No. 226 / Friday, November 25, 2022 / Notices
purposes of this Investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
1-Hydroxyethylidene-1, 1Diphosphonic Acid (HEDP) From China
Determination
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
countervailing and antidumping duty
orders on 1-hydroxyethylidene-1, 1diphosphonic acid from China would be
likely to lead to continuation or
recurrence of material injury to an
industry in the United States within a
reasonably foreseeable time.
Background
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
[Investigation Nos. 701–TA–558 and 731–
TA–1316 (Review)]
The Commission instituted these
reviews on April 1, 2022 (87 FR 19125)
and determined on July 5, 2022 that it
would conduct expedited reviews (87
FR 64248, October 24, 2022).
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
Jkt 259001
[FR Doc. 2022–25686 Filed 11–23–22; 8:45 am]
Certain Fitness Devices, Streaming
Components Thereof, and Systems
Containing Same; Notice of
Commission Determination To Review
the Final Initial Determination in Part;
Request for Written Submissions on
the Issues Under Review and on
Remedy, the Public Interest, and
Bonding
[FR Doc. 2022–25631 Filed 11–23–22; 8:45 am]
18:43 Nov 23, 2022
By order of the Commission.
Issued: November 18, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[Investigation No. 337–TA–1265]
By order of the Commission.
Issued: November 18, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
VerDate Sep<11>2014
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on November 18, 2022.
The views of the Commission are
contained in USITC Publication 5386
(November 2022), entitled 1Hydroxyethylidene-1, 1-Diphosphonic
Acid (HEDP) from China: Investigation
Nos. 701–TA–558 and 731–TA–1316
(Review).
Notice is hereby given that
the U.S. International Trade
Commission has determined to review
in part the final initial determination
(‘‘Final ID’’) issued by the presiding
chief administrative law judge (‘‘CALJ’’)
on September 9, 2022. The Commission
requests briefing from the parties on
certain issues under review, as
indicated in this notice. The
Commission also requests briefing from
the parties, interested government
agencies, and interested persons on the
issues of remedy, the public interest,
and bonding.
FOR FURTHER INFORMATION CONTACT:
Ronald A. Traud, Esq., Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
205–3427. Copies of non-confidential
documents filed in connection with this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
under section 337 of the Tariff Act of
1930, as amended, 19 U.S.C. 1337, on
May 19, 2021, based on a complaint
filed by DISH DBS Corporation of
Englewood, Colorado; DISH
Technologies, L.L.C., of Englewood,
Colorado; and Sling TV L.L.C., of
Englewood, Colorado (collectively,
‘‘DISH’’). 86 FR 27106–07 (May 19,
2021). The complaint alleged a violation
of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain fitness devices, streaming
components thereof, and systems
containing same by reason of
infringement of certain claims of U.S.
Patent Nos. 9,407,564 (‘‘the ’564
patent’’); 10,469,554 (‘‘the ’554 patent’’);
10,469,555 (‘‘the ’555 patent’’);
10,757,156 (‘‘the ’156 patent’’); and
10,951,680 (‘‘the ’680 patent’’). Id. at
27106. The notice of investigation
named as respondents ICON Health &
Fitness, Inc. of Logan, Utah (‘‘ICON’’ or
‘‘iFIT Inc.’’); FreeMotion Fitness, Inc. of
Logan, Utah (‘‘FreeMotion’’);
NordicTrack Inc. of Logan, Utah
(‘‘NordicTrack,’’ and with ICON and
FreeMotion, ‘‘iFit’’); lululemon athletica
inc., of Vancouver, Canada
(‘‘lululemon’’); Curiouser Products Inc.
d/b/a MIRROR of New York, New York
(together with lululemon, ‘‘MIRROR’’);
and Peloton Interactive, Inc. of New
York, New York (‘‘Peloton,’’ and with
the other respondents, ‘‘Respondents’’).
Id.; Order No. 14 (Nov. 4, 2021),
unreviewed by Comm’n Notice (Dec. 6,
2021), 86 FR 70532 (Dec. 10, 2021). The
Commission’s Office of Unfair Import
Investigations (‘‘OUII’’) also was named
as a party in this investigation. 86 FR at
27106.
Prior to the issuance of the Final ID,
the complaint and notice of
investigation were amended to change
the name of ICON to iFIT Inc. Order No.
14 (Nov. 4, 2021), unreviewed by
Comm’n Notice (Dec. 6, 2021), 86 FR at
70532. The investigation was also
terminated in part as to claims 6, 11,
and 12 of the ’156 patent, claim 22 of
the ’554 patent, and claim 17 of the ’555
patent. Order No. 15 (Nov. 19, 2021),
unreviewed by Comm’n Notice (Dec. 20,
2021). Moreover, claims 9 and 12 of the
’156 patent, claim 19 of the ’554 patent,
claims 12 and 13 of the ’555 patent, and
claim 6 of the ’564 patent are no longer
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 87, Number 226 (Friday, November 25, 2022)]
[Notices]
[Page 72510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25686]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 701-TA-558 and 731-TA-1316 (Review)]
1-Hydroxyethylidene-1, 1-Diphosphonic Acid (HEDP) From China
Determination
On the basis of the record \1\ developed in the subject five-year
reviews, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that revocation of the countervailing and antidumping duty
orders on 1-hydroxyethylidene-1, 1-diphosphonic acid from China would
be likely to lead to continuation or recurrence of material injury to
an industry in the United States within a reasonably foreseeable time.
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------
Background
The Commission instituted these reviews on April 1, 2022 (87 FR
19125) and determined on July 5, 2022 that it would conduct expedited
reviews (87 FR 64248, October 24, 2022).
The Commission made these determinations pursuant to section 751(c)
of the Act (19 U.S.C. 1675(c)). It completed and filed its
determinations in these reviews on November 18, 2022. The views of the
Commission are contained in USITC Publication 5386 (November 2022),
entitled 1-Hydroxyethylidene-1, 1-Diphosphonic Acid (HEDP) from China:
Investigation Nos. 701-TA-558 and 731-TA-1316 (Review).
By order of the Commission.
Issued: November 18, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022-25686 Filed 11-23-22; 8:45 am]
BILLING CODE 7020-02-P
